Ohdo S[au] - Search Results

Year	Number of Results
1979	1
1980	1
1981	1
1982	1
1983	2
1985	1
1986	1
1987	3
1988	6
1989	7
1990	3
1991	5
1992	8
1993	6
1994	2
1995	6
1996	8
1997	9
1998	4
1999	2
2000	4
2001	9
2002	9
2003	10
2004	5
2005	10
2006	9
2007	8
2008	10
2009	5
2010	12
2011	7
2012	8
2013	10
2014	6
2015	4
2016	7
2017	5
2018	8
2019	7
2020	5
2021	6
2022	2

1

Alteration of circadian machinery in monocytes underlies chronic kidney disease-associated cardiac inflammation and fibrosis.

Yoshida Y, Matsunaga N, Nakao T, Hamamura K, Kondo H, Ide T, Tsutsui H, Tsuruta A, Kurogi M, Nakaya M, Kurose H, Koyanagi S, Ohdo S. Yoshida Y, et al. Among authors: ohdo s. Nat Commun. 2021 May 13;12(1):2783. doi: 10.1038/s41467-021-23050-x. Nat Commun. 2021. PMID: 33986294 Free PMC article.

2

[Chronopharmacology].

Ohdo S, Koyanagi S, Matsunaga N. Ohdo S, et al. Nihon Yakurigaku Zasshi. 2011 Mar;137(3):115-9. doi: 10.1254/fpj.137.115. Nihon Yakurigaku Zasshi. 2011. PMID: 21415558 Review. Japanese. No abstract available.

3

Molecular basis of chronopharmaceutics.

Ohdo S, Koyanagi S, Matsunaga N, Hamdan A. Ohdo S, et al. J Pharm Sci. 2011 Sep;100(9):3560-76. doi: 10.1002/jps.22656. Epub 2011 Jun 7. J Pharm Sci. 2011. PMID: 21656520 Review.

4

Chronopharmacological strategies focused on chrono-drug discovery.

Ohdo S, Koyanagi S, Matsunaga N. Ohdo S, et al. Pharmacol Ther. 2019 Oct;202:72-90. doi: 10.1016/j.pharmthera.2019.05.018. Epub 2019 Jun 5. Pharmacol Ther. 2019. PMID: 31173839 Review.

5

[Biological clock and chronopharmacology].

Ohdo S. Ohdo S. Nihon Shinkei Seishin Yakurigaku Zasshi. 2007 Jun;27(3):95-102. Nihon Shinkei Seishin Yakurigaku Zasshi. 2007. PMID: 17633520 Review. Japanese.

6

Asthma: Chronopharmacotherapy and the molecular clock.

Burioka N, Fukuoka Y, Koyanagi S, Miyata M, Takata M, Chikumi H, Takane H, Watanabe M, Endo M, Sako T, Suyama H, Ohdo S, Shimizu E. Burioka N, et al. Among authors: ohdo s. Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):946-55. doi: 10.1016/j.addr.2010.03.012. Epub 2010 Mar 30. Adv Drug Deliv Rev. 2010. PMID: 20359514 Review.

7

Chrono-Drug Discovery and Development Based on Circadian Rhythm of Molecular, Cellular and Organ Level.

Ohdo S. Ohdo S. Biol Pharm Bull. 2021;44(6):747-761. doi: 10.1248/bpb.b21-00277. Biol Pharm Bull. 2021. PMID: 34078807 Free article. Review.

8

Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines.

Sato M, Fuchida H, Shindo N, Kuwata K, Tokunaga K, Xiao-Lin G, Inamori R, Hosokawa K, Watari K, Shibata T, Matsunaga N, Koyanagi S, Ohdo S, Ono M, Ojida A. Sato M, et al. Among authors: ohdo s. ACS Med Chem Lett. 2020 Apr 8;11(6):1137-1144. doi: 10.1021/acsmedchemlett.9b00574. eCollection 2020 Jun 11. ACS Med Chem Lett. 2020. PMID: 32550993 Free PMC article.

9

Chronopharmaceutics: pharmaceutics focused on biological rhythm.

Ohdo S. Ohdo S. Biol Pharm Bull. 2010;33(2):159-67. doi: 10.1248/bpb.33.159. Biol Pharm Bull. 2010. PMID: 20118534 Free article. Review.

10

Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.

Ogino T, Matsunaga N, Tanaka T, Tanihara T, Terajima H, Yoshitane H, Fukada Y, Tsuruta A, Koyanagi S, Ohdo S. Ogino T, et al. Among authors: ohdo s. Elife. 2021 Apr 23;10:e66155. doi: 10.7554/eLife.66155. Elife. 2021. PMID: 33890571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results